A new staging system that integrates tumor deposits with lymph node counts provides superior survival stratification and ...

Here the authors report that excessive mtROS induces the release of mitochondrial PGAM5 into cytoplasm and subsequent dephosphorylation of MST3 kinase, promoting colorectal cancer progression.

Barry Stein initially ignored his symptoms in 1995, until he was eventually diagnosed with stage 4 colorectal cancer. (Photo provided by Stein) Colorectal cancer cancer grows more slowly than some ...

With a face like mine I don't break any hearts and because I have a face like mine I don't take many selfies. (And the ones I do take are just so my dermatologist team can see how my face is ...

How you feel after your bowel (colon) cancer operation depends on what type of surgery you have. After a big operation, you might wake up in the intensive care unit (ICU) or high dependency unit (HDU) ...

The first African American Rockette to dance at Radio City Music Hall, Tony Award winner, and now colon cancer survivor — that’s Jennifer Jones. Jennifer Jones joined the Rockettes in 1988. Before ...

The test was 81% accurate in detecting colon cancer among people with the disease It also was 90% accurate in ruling out colon cancer among healthy people TUESDAY, Jan. 28, 2025 (HealthDay News) -- An ...

A second blood test shows promise for the detection of colon cancer, according to a new study. The first, called Shield, was approved by the Food and Drug Administration in July for people 45 and ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the cancer ...

Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ability to treat colorectal cancer. The plant is a common herb.

Clinical-pathological characteristics, follow-up, and survival of patients with early-onset vs late-onset colorectal cancer: Institutional experience in Argentina. Long-term outcomes of total ...

Safety and biomarker assessment of ST316, a novel peptide antagonist of ß-catenin, in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...